Differently, in non-small cell lung cancer (NSCLC), an epigenetic mechanism under HDAC1 control regulates cisplatin resistance by suppressing the expression of ornithine decarboxylase antizyme 1 (OAZ1)[40]. The gene discussed is OAZ1; the disease is non-small cell lung carcinoma.